Learning from the nexus of autoimmunity and cancer

Cancer immunotherapy using checkpoint blockade

Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671

PD-1 and Its Ligands in Tolerance and Immunity

Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378

NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses

Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182

The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer

Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,090

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy

Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888

Molecular and genetic properties of tumors associated with local immune cytolytic activity

Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M., Ferguson, P., Whitesell, L., Kelly, T., Saulsbury, F., Chance, P., & Ochs, H. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,576

CTLA-4 Control over Foxp3 + Regulatory T Cell Function

Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914

Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4

Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766

The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases

Bach, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,723

Regulation and Function of NF-κB Transcription Factors in the Immune System

Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,635

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B. W., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D. J., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,628

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Martins, F., Sofiya, L., Sykiotis, G. P., Lamine, F., Maillard, M., Fraga, M., Shabafrouz, K., Ribi, C., Cairoli, A., Guex-Crosier, Y., et al. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0218-0 · Cited by 2,314

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.

Krummel, M. F., & Allison, J. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.459 · Cited by 2,245

Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old

Adams, K. F., Schatzkin, A. G., Harris, T. B., Kipnis, V., Mouw, T., Ballard-Barbash, R. R., Hollenbeck, A. R., & Leitzmann, M. F. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055643 · Cited by 2,147

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

Forde, P. M., Chaft, J. E., Smith, K. N., Anagnostou, V., Cottrell, T. R., Hellmann, M. D., Zahurak, M., Yang, S. C., Jones, D. R., Broderick, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716078 · Cited by 2,099

Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation

Anderson, A. C., Joller, N., & Kuchroo, V. K. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.001 · Cited by 2,096

Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

Miller, B. C., Sen, D. R., Al Abosy, R., Bi, K., Virkud, Y. V., LaFleur, M. W., Yates, K. B., Lako, A., Felt, K., Naik, G. S., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0312-6 · Cited by 2,087

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

Im, S. J., Hashimoto, M., Gerner, M. Y., Lee, J., Kissick, H. T., Burger, M. C., Shan, Q., Hale, J. S., Lee, J., Nasti, T. H., et al. (2016) · Nature · doi:10.1038/nature19330 · Cited by 2,070

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., et al. (2022) · Science · doi:10.1126/science.abj8222 · Cited by 2,049

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

on behalf of the Society for Immunotherapy of Cancer Toxicity Management Working Group, Puzanov, I., Diab, A., Abdallah, K., Bingham, C. O., Brogdon, C., Dadu, R., Hamad, L., Kim, S., Lacouture, M. E., et al. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0300-z · Cited by 1,992

Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis

Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858

Mechanisms involved in the side effects of glucocorticoids

SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847

Immune regulation by glucocorticoids

Cain, D. W., & Cidlowski, J. A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.1 · Cited by 1,846

Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice

Kim, J. M., Rasmussen, J. P., & Rudensky, A. Y. (2006) · Nature Immunology · doi:10.1038/ni1428 · Cited by 1,827

Human papillomavirus oncoproteins: pathways to transformation

Moody, C. A., & Laimins, L. A. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2886 · Cited by 1,814

Biomarker definitions and their applications

Califf, R. M. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370217750088 · Cited by 1,687

Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy

Siddiqui, I., Schaeuble, K., Chennupati, V., Fuertes Marraco, S. A., Calderon-Copete, S., Pais Ferreira, D., Carmona, S. J., Scarpellino, L., Gfeller, D., Pradervand, S., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.021 · Cited by 1,679

A decade of immune-checkpoint inhibitors in cancer therapy

Robert, C. (2020) · Nature Communications · doi:10.1038/s41467-020-17670-y · Cited by 1,608

CD4+ T cell help in cancer immunology and immunotherapy

Borst, J., Ahrends, T., Bąbała, N., Melief, C. J. M., & Kastenmüller, W. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0044-0 · Cited by 1,585

Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone

Jonat, C., Rahmsdorf, H. J., Park, K.-K., Cato, A. C. B., Gebel, S., Ponta, H., & Herrlich, P. (1990) · Cell · doi:10.1016/0092-8674(90)90395-u · Cited by 1,544

Tumour-intrinsic resistance to immune checkpoint blockade

Kalbasi, A. K., & Ribas, A. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0218-4 · Cited by 1,525

CD8+ T cell states in human cancer: insights from single-cell analysis

van der Leun, A. M., Thommen, D. S., & Schumacher, T. N. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-019-0235-4 · Cited by 1,487

CRISPR-engineered T cells in patients with refractory cancer

Stadtmauer, E. A., Fraietta, J. A., Davis, M. M., Cohen, A. D., Weber, K. L., Lancaster, E., Mangan, P. A., Kulikovskaya, I., Gupta, M., Chen, F., et al. (2020) · Science · doi:10.1126/science.aba7365 · Cited by 1,478

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

Simpson, T. R., Li, F., Montalvo-Ortiz, W., Sepulveda, M. A., Bergerhoff, K., Arce, F., Roddie, C., Henry, J. Y., Yagita, H., Wolchok, J. D., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130579 · Cited by 1,472

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L.-P., Gimotty, P. A., Gilks, C. B., Lal, P., Zhang, L., et al. (2011) · Nature · doi:10.1038/nature10169 · Cited by 1,376

Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates

Simoni, Y., Becht, E., Fehlings, M., Loh, C. Y., Koo, S.-L., Teng, K. W. W., Yeong, J. P. S., Nahar, R., Zhang, T., Kared, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0130-2 · Cited by 1,370

T Cell Dysfunction in Cancer

Thommen, D. S., & Schumacher, T. N. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.012 · Cited by 1,351

Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade

Pauken, K. E., Sammons, M. A., Odorizzi, P. M., Manne, S., Godec, J., Khan, O., Drake, A. M., Chen, Z., Sen, D. R., Kurachi, M., et al. (2016) · Science · doi:10.1126/science.aaf2807 · Cited by 1,348

Staging presymptomatic type 1 diabetes: A scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association

Insel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216

Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood

Ziv, Y., Ron, N., Butovsky, O., Landa, G., Sudai, E., Greenberg, N., Cohen, H., Kipnis, J., & Schwartz, M. (2006) · Nature Neuroscience · doi:10.1038/nn1629 · Cited by 1,209

T Cell Factor 1-Expressing Memory-like CD8+ T Cells Sustain the Immune Response to Chronic Viral Infections

Utzschneider, D. T., Charmoy, M., Chennupati, V., Pousse, L., Ferreira, D. P., Calderon-Copete, S. P., Danilo, M., Alfei, F., Hofmann, M., Wieland, D., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.021 · Cited by 1,095

CD8+ T cell differentiation and dysfunction in cancer

Philip, M., & Schietinger, A. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00574-3 · Cited by 1,052

Microglial control of astrocytes in response to microbial metabolites

Rothhammer, V., Borucki, D. M., Tjon, E. C., Takenaka, M. C., Chao, C.-C., Ardura-Fabregat, A., de Lima, K. A., Gutiérrez-Vázquez, C., Hewson, P., Staszewski, O., et al. (2018) · Nature · doi:10.1038/s41586-018-0119-x · Cited by 1,051

PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer

Kamada, T., Togashi, Y., Tay, C., Ha, D., Sasaki, A., Nakamura, Y., Sato, E., Fukuoka, S., Tada, Y., Tanaka, A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1822001116 · Cited by 1,035

Systemic Immunity Is Required for Effective Cancer Immunotherapy

Spitzer, M. H., Carmi, Y., Reticker-Flynn, N. E., Kwek, S. S., Madhireddy, D., Martins, M. M., Gherardini, P. F., Prestwood, T. R., Chabon, J., Bendall, S. C., et al. (2017) · Cell · doi:10.1016/j.cell.2016.12.022 · Cited by 963

Organ-specific disease provoked by systemic autoimmunity.

Kouskoff, V., Korganow, A., Duchatelle, V., Degott, C., Benoist, C., & Mathis, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81989-3 · Cited by 949

Multiple Sclerosis: Mechanisms and Immunotherapy

Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938

Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes

Sm, L., Dayan, C. M., Bishop, A. J., Roep, B. O., Peakman, M., & Tree, T. I. M. (2005) · Diabetes · doi:10.2337/diabetes.54.1.92 · Cited by 881

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

Blank, C. U., Rozeman, E. A., Fanchi, L. F., Sikorska, K., van de Wiel, B., Kvistborg, P., Krijgsman, O., van den Braber, M., Philips, D., Broeks, A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0198-0 · Cited by 880

Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4

Kuehn, H. S., Ouyang, W., Lo, B., Deenick, E. K., Niemela, J. E., Avery, D. T., Schickel, J., Tran, D. Q., Stoddard, J. L., Zhang, Y., et al. (2014) · Science · doi:10.1126/science.1255904 · Cited by 879

The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells

Martinez, G. J., Pereira, R. M., Äijö, T., Kim, E. Y., Marangoni, F., Pipkin, M. E., Togher, S., Heissmeyer, V., Zhang, Y. C., Crotty, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.006 · Cited by 857

Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells

Selby, M. J., Engelhardt, J. J., Quigley, M., Henning, K. A., Chen, T., Srinivasan, M., & Korman, A. J. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0013 · Cited by 857

Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms

Tay, R. E., Richardson, E. K., & Toh, H. C. (2020) · Cancer Gene Therapy · doi:10.1038/s41417-020-0183-x · Cited by 844

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

Amaria, R. N., Reddy, S. M., Tawbi, H. A., Davies, M. A., Ross, M. I., Glitza, I. C., Cormier, J. N., Lewis, C., Hwu, W.-J., Hanna, E., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0197-1 · Cited by 835

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo

Chen, M.-L., Pittet, M. J., Gorelik, L., Flavell, R. A., Weissleder, R., von Boehmer, H., & Khazaie, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408197102 · Cited by 806

TH17 Cells Mediate Steroid-Resistant Airway Inflammation and Airway Hyperresponsiveness in Mice

McKinley, L., Alcorn, J. F., Peterson, A., DuPont, R., Kapadia, S. B., Logar, A., Henry, A. C., Irvin, C. G., Piganelli, J. D., Ray, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4089 · Cited by 783

Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes

Jäger, A., Dardalhon, V., Sobel, R. A., Bettelli, E., & Kuchroo, V. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901906 · Cited by 783

Obesity and cancer

Wolin, K. Y., Carson, K., & Colditz, G. A. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0285 · Cited by 778

Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis

Schietinger, A., Philip, M., Krisnawan, V. E., Chiu, E. Y., Delrow, J. J., Basom, R. S., Lauer, P., Brockstedt, D. G., Knoblaugh, S. E., Hämmerling, G. J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.011 · Cited by 720

Recognition of the Peripheral Self by Naturally Arising CD25+ CD4+ T Cell Receptors

Hsieh, C., Liang, Y., Tyznik, A. J., Self, S. G., Liggitt, D., & Rudensky, A. Y. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.009 · Cited by 719

Unexpected role of interferon-γ in regulating neuronal connectivity and social behaviour

Filiano, A. J., Xu, Y., Tustison, N. J., Marsh, R. L., Baker, W., Smirnov, I., Overall, C. C., Gadani, S. P., Turner, S. D., Weng, Z., et al. (2016) · Nature · doi:10.1038/nature18626 · Cited by 697

A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma

Huang, A. C. C., Orlowski, R. J., Xu, X., Mick, R., George, S. M., Yan, P., Manne, S., Kraya, A., Wubbenhorst, B. S., Dorfman, L. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0357-y · Cited by 696

Obesity in autoimmune diseases: Not a passive bystander

Versini, M., Jeandel, P.-Y., Rosenthal, E., & Shoenfeld, Y. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.07.001 · Cited by 694

T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection

McKinney, E. F., Lee, J. C., Jayne, D. R. W., Lyons, P. A., & Smith, K. G. C. (2015) · Nature · doi:10.1038/nature14468 · Cited by 685

CD4+ T Cell Help Is Required for the Formation of a Cytolytic CD8+ T Cell Subset that Protects against Chronic Infection and Cancer

Zander, R., Schauder, D., Xin, G., Nguyen, C. P., Wu, X., Zajac, A. J., & Cui, W. (2019) · Immunity · doi:10.1016/j.immuni.2019.10.009 · Cited by 660

Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells

Kurtulus, S., Madi, A., Escobar, G., Klapholz, M., Nyman, J., Christian, E., Pawlak, M., Dionne, D., Xia, J., Rozenblatt-Rosen, O., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.11.014 · Cited by 636

NFAT, immunity and cancer: a transcription factor comes of age

Müller, M., & Rao, A. (2010) · Nature reviews. Immunology · doi:10.1038/nri2818 · Cited by 611

cDC1 prime and are licensed by CD4(+) T cells to induce anti-tumour immunity

Ferris, S. T., Durai, V., Wu, R., Theisen, D. J., Ward, J. P., Bern, M. D., Davidson, J. T., Bagadia, P., Liu, T., Briseño, C. G., et al. (2020) · Nature · doi:10.1038/s41586-020-2611-3 · Cited by 611

Defining the Role of the MHC in Autoimmunity: A Review and Pooled Analysis

Fernando, M. M. A., Stevens, C. R., Walsh, E. C., Jager, P. L. D., Goyette, P., Plenge, R. M., Vyse, T. J., & Rioux, J. D. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000024 · Cited by 603

Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies

Arce Vargas, F., Furness, A. J. S., Litchfield, K., Joshi, K., Rosenthal, R., Ghorani, E., Solomon, I., Lesko, M. H., Ruef, N., Roddie, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.02.010 · Cited by 592

Dysfunctional Blood and Target Tissue CD4+CD25high Regulatory T Cells in Psoriasis: Mechanism Underlying Unrestrained Pathogenic Effector T Cell Proliferation

Sugiyama, H., Gyulai, R., Toichi, E., Garaczi, E., Shimada, S., Stevens, S. R., McCormick, T. S., & Cooper, K. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.164 · Cited by 571

The MHC locus and genetic susceptibility to autoimmune and infectious diseases

Matzaraki, V., Kumar, V., Wijmenga, C., & Zhernakova, A. (2017) · Genome biology · doi:10.1186/s13059-017-1207-1 · Cited by 566

Genetic risk factors for type 1 diabetes

Pociot, F., & Lernmark, Å. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30582-7 · Cited by 553

Clinical Challenges of Immune Checkpoint Inhibitors

Miguel, M. J. D., & Calvo, E. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.07.004 · Cited by 549

An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires

Hsieh, C., Zheng, Y., Liang, Y., Fontenot, J. D., & Rudensky, A. Y. (2006) · Nature Immunology · doi:10.1038/ni1318 · Cited by 540

HIV-Associated Cancers and Related Diseases

Yarchoan, R., & Uldrick, T. S. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1615896 · Cited by 534

Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease: A Systematic Review

Abdel-Wahab, N., Shah, M., Lopez-Olivo, M. A., & Suarez-Almazor, M. E. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2073 · Cited by 487

High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma

Faje, A. T., Lawrence, D., Flaherty, K., Freedman, C., Fadden, R., Rubin, K., Cohen, J., & Sullivan, R. J. (2018) · Cancer · doi:10.1002/cncr.31629 · Cited by 486

Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells

Odorizzi, P. M., Pauken, K. E., Paley, M., Sharpe, A. H., & Wherry, E. J. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20142237 · Cited by 480

The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action

Simmonds, M., & Gough, S. (2007) · Current Genomics · doi:10.2174/138920207783591690 · Cited by 472

Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox

Oh, D. Y., & Fong, L. (2021) · Immunity · doi:10.1016/j.immuni.2021.11.015 · Cited by 467

Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids

Ramesh, R., Kozhaya, L., McKevitt, K., Djuretic, I. M., Carlson, T. J., Quintero, M. A., McCauley, J. L., Abreu, M. T., Unutmaz, D., & Sundrud, M. S. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20130301 · Cited by 447

A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death

D'Adamio, F., Zollo, O., Moraca, R., Ayroldi, E., Bruscoli, S., Bartoli, A., Cannarile, L., Migliorati, G., & Riccardi, C. (1997) · Immunity · doi:10.1016/s1074-7613(00)80398-2 · Cited by 444

Stable inhibitory activity of regulatory T cells requires the transcription factor Helios

Kim, H.-J., Barnitz, R. A., Kreslavsky, T., Brown, F. D., Moffett, H., Lemieux, M. E., Kaygusuz, Y., Meissner, T., Holderried, T. A. W., Chan, S., et al. (2015) · Science · doi:10.1126/science.aad0616 · Cited by 441

Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion.

Bouneaud, C., Kourilsky, P., & Bousso, P. (2000) · Immunity · doi:10.1016/s1074-7613(00)00080-7 · Cited by 431

Blocked Signal Transduction to the ERK and JNK Protein Kinases in Anergic CD4 + T Cells

Li, W., Whaley, C. D., Mondino, A., & Mueller, D. L. (1996) · Science · doi:10.1126/science.271.5253.1272 · Cited by 427

A reservoir of stem-like CD8 + T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response

Connolly, K. A., Kuchroo, M. R., Venkat, A., Khatun, A., Wang, J., William, I., Hornick, N. I., Fitzgerald, B., Damo, M., Kasmani, M. Y., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg7836 · Cited by 415

Androgen receptor activity in T cells limits checkpoint blockade efficacy

Guan, X., Polesso, F., Wang, C., Sehrawat, A., Hawkins, R. M., Murray, S., THOMAS, G. V., Caruso, B., Thompson, R. F., Wood, M. A., et al. (2022) · Nature · doi:10.1038/s41586-022-04522-6 · Cited by 408

Lymph node colonization induces tumor-immune tolerance to promote distant metastasis

Reticker-Flynn, N. E., Zhang, W., Belk, J. A., Basto, P. A., Escalante, N. K., Pilarowski, G. O. W., Bejnood, A., Martins, M. M., Kenkel, J. A., Linde, I. L., et al. (2022) · Cell · doi:10.1016/j.cell.2022.04.019 · Cited by 399

Genome-wide association studies of cancer: current insights and future perspectives

Sud, A., Kinnersley, B., & Houlston, R. S. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.82 · Cited by 391

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives

Thomas, R., Al‐Khadairi, G., Roelands, J. P., Hendrickx, W., Dermime, S., Bedognetti, D., & Decock, J. V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00947 · Cited by 388

Passive or Active Immunization with Myelin Basic Protein Promotes Recovery from Spinal Cord Contusion

Hauben, E., Butovsky, O., Nevo, U., Yoles, E., Moalem‐Taylor, G., Agranov, E., Mor, F., Leibowitz‐Amit, R., Pevsner, E., AKSELROD, S., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06421.2000 · Cited by 367

Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats.

Saad, M. J., Folli, F., Kahn, J. A., & Kahn, C. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116803 · Cited by 349

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2

Lünemann, J. D., Jelčić, I., Roberts, S., Lutterotti, A., Tackenberg, B., Martinꝉ, R., & Münz, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072397 · Cited by 348

The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response

Sánchez‐Alcoholado, L., Ramos‐Molina, B., Otero, A. P., Laborda-Illanes, A., Ordóñez, R., Medina, J. A., Gómez‐Millán, J., & Queipo‐Ortuño, M. I. (2020) · Cancers · doi:10.3390/cancers12061406 · Cited by 346

TIM3+FOXP3+regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer

Sakuishi, K., Ngiow, S. F., Sullivan, J. M., Teng, M. W. L., Kuchroo, V. K., Smyth, M. J., & Anderson, A. C. (2013) · OncoImmunology · doi:10.4161/onci.23849 · Cited by 340

Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer

Cachot, A., Bilous, M., Liu, Y., Li, X., Saillard, M., Cenerenti, M., Rockinger, G. A., Wyss, T., Guillaume, P., Schmidt, J., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe3348 · Cited by 340

Tumors induce de novo steroid biosynthesis in T cells to evade immunity

Mahata, B., Pramanik, J., van der Weyden, L., Polański, K., Kar, G., Riedel, A., Chen, X. X., Fonseca, N. A., Kundu, K., Campos, L. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17339-6 · Cited by 333

Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway

Fife, B. T., Guleria, I., Bupp, M. G., Eagar, T. N., Tang, Q., Bour-Jordan, H., Yagita∥, H., Azuma, M., Sayegh, M. H., & Bluestone, J. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061577 · Cited by 331

Analysis of regulatory CD8 T cells in Qa-1-deficient mice

Hu, D., Ikizawa, K., Lu, L., Sanchirico, M. E., Shinohara, M. L., & Cantor, H. (2004) · Nature Immunology · doi:10.1038/ni1063 · Cited by 330

CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis

Wolf, S. A., Steiner, B., Akpinarli, A., Kammertoens, T., Nassenstein, C., Braun, A., Blankenstein, T., & Kempermann, G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801218 · Cited by 329

Exhaustion-associated regulatory regions in CD8 + tumor-infiltrating T cells

Mognol, G. P., Spreafico, R., Wong, V., Scott-Browne, J. P., Togher, S., Hoffmann, A., Hogan, P. G., Rao, A., & Trifari, S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620498114 · Cited by 324

Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8+ T Lymphocytes

Yu, W., Jiang, N. J., Ebert, P. J. R., Kidd, B. A., Müller, S., Lund, P. J., Juang, J., Adachi, K., Tse, T., Birnbaum, M. E., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.05.001 · Cited by 314

Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis

Cao, Y., Goods, B. A., Raddassi, K., Nepom, G. T., Kwok, W. W., Love, J. C., & Hafler, D. A. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa8038 · Cited by 306

Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy

Rosato, P. C., Wijeyesinghe, S., Stolley, J. M., Nelson, C. E., Davis, R. L., Manlove, L. S., Pennell, C. A., Blazar, B. R., Chen, C. C., Geller, M. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08534-1 · Cited by 304

Glucocorticoids, Sex Hormones, and Immunity

Bereshchenko, O., Bruscoli, S., & Riccardi, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01332 · Cited by 282

Rethinking peripheral T cell tolerance: checkpoints across a T cell’s journey

ElTanbouly, M. A., & Noelle, R. J. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00454-2 · Cited by 282

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

Aminkeng, F., Bhavsar, A. P., Visscher, H., Rassekh, S. R., Li, Y., Lee, J. W., Brunham, L. R., Caron, H. N., van Dalen, E. C., Kremer, L. C. M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3374 · Cited by 280

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

(2018) · New England Journal of Medicine · doi:10.1056/nejmc1808251 · Cited by 277

Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice

Hill, J. A., Bell, D., Brintnell, W. C., Yue, D., Wehrli, B. M., Jevnikar, A. M., Lee, D. M., Hueber, W., Robinson, W. H., & Cairns, E. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072051 · Cited by 275

Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review

Axley, P. D., Ahmed, Z., Ravi, S., & Singal, A. K. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00067 · Cited by 275

Immune checkpoint inhibitor-induced colitis: A comprehensive review

Som, A., Mandaliya, R. H., Alsaadi, D., Farshidpour, M., Charabaty, A., Malhotra, N., & Mattar, M. C. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i4.405 · Cited by 271

PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance

Tan, C. L., Kuchroo, J. R., Sage, P. T., Liang, D., Francisco, L. M., Buck, J. N., Thaker, Y. R., Zhang, Q., McArdel, S. L., Juneja, V. R., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20182232 · Cited by 269

Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity

Vignali, P. D. A., DePeaux, K., Watson, M. J., Ye, C., Ford, B. R., Lontos, K., McGaa, N. K., Scharping, N. E., Menk, A. V., Robson, S. C., et al. (2023) · Nature Immunology · doi:10.1038/s41590-022-01379-9 · Cited by 269

Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity

Schnell, A., Huang, L., Singer, M., Singaraju, A., Barilla, R. M., Regan, B. M. L., Bollhagen, A., Thakore, P. I., Dionne, D., Delorey, T. M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.11.018 · Cited by 268

Endogenous Glucocorticoid Signaling Regulates CD8+ T Cell Differentiation and Development of Dysfunction in the Tumor Microenvironment

Acharya, N., Madi, A., Zhang, H., Klapholz, M., Escobar, G., Dulberg, S., Christian, E., Ferreira, M., Dixon, K. O., Fell, G. G., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.005 · Cited by 257

An autoimmune stem-like CD8 T cell population drives type 1 diabetes

Gearty, S. V., Dündar, F., Zumbo, P., Espinosa-Carrasco, G., Shakiba, M., Sanchez-Rivera, F. J., Socci, N. D., Trivedi, P., Lowe, S. W., Lauer, P., et al. (2022) · Nature · doi:10.1038/s41586-021-04248-x · Cited by 257

Therapeutic targeting of regulatory T cells in cancer

Shan, F., Somasundaram, A., Bruno, T. C., Workman, C. J., & Vignali, D. A. A. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.06.008 · Cited by 255

Androgen conspires with the CD8 + T cell exhaustion program and contributes to sex bias in cancer

Kwon, H., Schafer, J. M., Song, N., Kaneko, S., Li, A., Xiao, T., Ma, A., Allen, C., Das, K., Zhou, L., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abq2630 · Cited by 254

Association analyses identify 31 new risk loci for colorectal cancer susceptibility

Law, P., Timofeeva, M. N., Fernández–Rozadilla, C., Broderick, P., Studd, J. B., Fernandez-Tajes, J. J., Farrington, S. M., Svinti, V., Palles, C., Orlando, G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09775-w · Cited by 249

KIR + CD8 + T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19

Li, J., Zaslavsky, M., Su, Y., Guo, J., Sikora, M. J., van Unen, V., Christophersen, A., Chiou, S.-H., Chen, L., Li, J., et al. (2022) · Science · doi:10.1126/science.abi9591 · Cited by 249

Glucocorticoids in T cell development, differentiation and function

Taves, M. D., & Ashwell, J. D. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00464-0 · Cited by 246

Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls

Timofeeva, M. N., Hung, R. J., Rafnar, Þ., Christiani, D. C., Field, J. K., Bickeböller, H., Risch, A., McKay, J., Wang, Y., Dai, J., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds334 · Cited by 235

The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity

Schnell, A., Bod, L., Madi, A., & Kuchroo, V. K. (2020) · Cell Research · doi:10.1038/s41422-020-0277-x · Cited by 234

Dysregulated T cell expression of TIM3 in multiple sclerosis

Koguchi, K., Anderson, D. E., Yang, L., O’Connor, K. C., Kuchroo, V. K., & Hafler, D. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060210 · Cited by 232

‘Stem-like’ precursors are the fount to sustain persistent CD8+ T cell responses

Zehn, D., Thimme, R., Lugli, E., de Almeida, G. P., & Oxenius, A. (2022) · Nature Immunology · doi:10.1038/s41590-022-01219-w · Cited by 232

CD8+CD28− T Regulatory Lymphocytes Inhibiting T Cell Proliferative and Cytotoxic Functions Infiltrate Human Cancers

Filaci, G., Fenoglio, D., Fravega, M., Ansaldo, G., Borgonovo, G., Traverso, P., Villaggio, B., Ferrera, A., Kunkl, A., Rizzi, M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4323 · Cited by 229

Biologics for targeting inflammatory cytokines, clinical uses, and limitations

Rider, P., Carmi, Y., & Cohen, I. (2016) · International Journal of Cell Biology · doi:10.1155/2016/9259646 · Cited by 226

Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases

Dragin, N., Bismuth, J., Cizeron-Clairac, G., Biferi, M. G., Berthault, C., Serraf, A. E., Nottin, R., Klatzmann, D., Cumano, A., Barkats, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81894 · Cited by 223

Single-Cell RNA Sequencing Reveals T Helper Cells Synthesizing Steroids De Novo to Contribute to Immune Homeostasis

Mahata, B., Zhang, X., Kolodziejczyk, A. A., Proserpio, V., Haim-Vilmovsky, L., TAYLOR, A. E. R., Hebenstreit, D., Dingler, F. A., Moignard, V., Göttgens, B., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.011 · Cited by 214

Opposing T cell responses in experimental autoimmune encephalomyelitis

Saligrama, N., Zhao, F., Sikora, M. J., Serratelli, W. S., Fernandes, R. A., Louis, D. M., Yao, W., Ji, X., Idoyaga, J., Mahajan, V. B., et al. (2019) · Nature · doi:10.1038/s41586-019-1467-x · Cited by 212

T cell factor 1: A master regulator of the T cell response in disease

Escobar, G., Mangani, D., & Anderson, A. C. (2020) · Science Immunology · doi:10.1126/sciimmunol.abb9726 · Cited by 211

Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases

Fragoulis, G. E., Siebert, S., & McInnes, I. B. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-051914-021944 · Cited by 203

Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals

Maeda, Y., Nishikawa, H., Sugiyama, D., Ha, D., Hamaguchi, M., Saito, T., Nishioka, M., Wing, J. B., Adeegbe, D. O., Katayama, I., et al. (2014) · Science · doi:10.1126/science.aaa1292 · Cited by 202

Androgen receptor-mediated CD8+ T cell stemness programs drive sex differences in antitumor immunity

Yang, C., Jin, J., Yang, Y., Sun, H., Wu, L., Shen, M., Hong, X., Li, W., Lu, L., Cao, D., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.05.012 · Cited by 195

The Role of Glucocorticoids in Inflammatory Diseases

Reichardt, S. D., Amouret, A., Muzzi, C., Vettorazzi, S., Tuckermann, J. P., Lühder, F., & Reichardt, H. M. (2021) · Cells · doi:10.3390/cells10112921 · Cited by 191

New therapeutic perspectives to manage refractory immune checkpoint-related toxicities

Martins, F., Sykiotis, G. P., Maillard, M. H., Fraga, M. C., Ribi, C., Küntzer, T., Michielin, O. A., Peters, S., Coukos, G., Spertini, F., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30828-3 · Cited by 190

Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator

Zhu, M., Bakhru, P., Conley, B. E., Nelson, J. S., Free, M. E., Martin, A. J., Starmer, J., Wilson, E. M., & Su, M. A. (2016) · Nature Communications · doi:10.1038/ncomms11350 · Cited by 181

Mechanism of gene expression by the glucocorticoid receptor: Role of protein‐protein interactions

McEwan, I. J., Wright, A. P. H., & Gustafsson, J.-Α. (1997) · BioEssays · doi:10.1002/bies.950190210 · Cited by 179

LAG3 limits regulatory T cell proliferation and function in autoimmune diabetes

Zhang, Q., Chikina, M. D., Szymczak-Workman, A. L., Horne, W. T., Kolls, J. K., Vignali, K. M., Normolle, D. P., Bettini, M., Workman, C. J., & Vignali, D. A. A. (2017) · Science Immunology · doi:10.1126/sciimmunol.aah4569 · Cited by 170

Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?

Derosa, L., Routy, B., Desilets, A., Daillère, R., Terrisse, S., Kroemer, G., & Zitvogel, L. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0236 · Cited by 170

Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor

Waldner, H., Whitters, M. J., Sobel, R. A., Collins, M. A., & Kuchroo, V. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3412 · Cited by 156

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1

Fachal, L., Gómez‐Caamaño, A., Barnett, G. C., Peleteiro, P., Carballo, A. M., Calvo, P., Kerns, S. L., Sánchez-García, M., Lobato-Busto, R., Dorling, L., et al. (2014) · Nature Genetics · doi:10.1038/ng.3020 · Cited by 151

Lack of TIM-3 Immunoregulation in Multiple Sclerosis

Yang, L., Anderson, D. E., Kuchroo, J. R., & Hafler, D. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4409 · Cited by 142

T cell vaccination induces T cell receptor Vβ-specific Qa-1-restricted regulatory CD8 + T cells

Jiang, H., Kashleva, H., Xu, L.-X., Forman, J., Flaherty, L. A., Pernis, B., Braunstein, N. S., & Chess, L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4533 · Cited by 133

GILZ Promotes Production of Peripherally Induced Treg Cells and Mediates the Crosstalk between Glucocorticoids and TGF-β Signaling

Bereshchenko, O., Coppo, M., Bruscoli, S., Biagioli, M., Cimino, M., Frammartino, T., Sorcini, D., Venanzi, A., Di Sante, M., & Riccardi, C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.004 · Cited by 131

The PD-1 Pathway Regulates Development and Function of Memory CD8+ T Cells following Respiratory Viral Infection

Pauken, K. E., Godec, J., Odorizzi, P. M., Brown, K. E., Yates, K. B., Ngiow, S. F., Burke, K. P., Maleri, S., Grande, S. M., Francisco, L. M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107827 · Cited by 124

Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections

Agrawal, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02631 · Cited by 124

Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways.

DeSilva, D. R., Feeser, W. S., Tancula, E. J., & Scherle, P. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.5.2017 · Cited by 121

HLA-E–restricted regulatory CD8+ T cells are involved in development and control of human autoimmune type 1 diabetes

Jiang, H., Canfield, S. M., Gallagher, M. P., Jiang, Y., Jiang, Y., Zheng, Z., & Chess, L. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43522 · Cited by 118

Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene

Cannarile, L., Zollo, O., D'Adamio, F., Ayroldi, E., Marchetti, C., Tabilio, A., Bruscoli, S., & Riccardi, C. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400798 · Cited by 117

Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child

Ogishi, M., Yang, R., Aytekin, C., Langlais, D., Bourgey, M., Khan, T., Ali, F. A., Rahman, M., Delmonte, O. M., Chrabieh, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01388-5 · Cited by 117

Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver

Tang, W., Zhou, J., Yang, W., Feng, Y., Wu, H., Mok, M. T. S., Zhang, L., Liang, Z., Liu, X., Xiong, Z., et al. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00872-3 · Cited by 113

Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome

Liu, J., O’Donnell, J. S., Yan, J., Madore, J., Allen, S. M., Smyth, M. J., & Teng, M. W. L. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1581530 · Cited by 112

Regulation of self-tolerance by Qa-1-restricted CD8+ regulatory T cells

Kim, H., & Cantor, H. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.06.001 · Cited by 111

Beneficial autoimmunity improves cancer prognosis

Zitvogel, L., Perreault, C., Finn, O. J., & Kroemer, G. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00508-x · Cited by 108

Obesity-Associated Alterations of Natural Killer Cells and Immunosurveillance of Cancer

Bähr, I., Spielmann, J., Quandt, D., & Kielstein, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00245 · Cited by 103

Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis

Correale, J. D., & Villa, A. M. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.12.004 · Cited by 102

Strategies for improving the management of immune-related adverse events

Naing, A., Hajjar, J., Gulley, J. L., Atkins, M. B., Ciliberto, G., Meric‐Bernstam, F., & Hwu, P. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001754 · Cited by 99

Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function

Dyck, L., Prendeville, H., Raverdeau, M., Wilk, M. M., Loftus, R. M., Douglas, A., McCormack, J., Moran, B., Wilkinson, M., Mills, E. L., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20210042 · Cited by 98

T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy

Garaud, S., Dieu‐Nosjean, M., & Willard-Gallo, K. E. (2022) · Nature Communications · doi:10.1038/s41467-022-29753-z · Cited by 98

Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses

Lo, J. A., Kawakubo, M., Juneja, V. R., Su, M. Y., Erlich, T. H., LaFleur, M. W., Kemeny, L. V., Rashid, M., Malehmir, M., Rabi, S. A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd8636 · Cited by 97

Effector T cells in rheumatoid arthritis: Lessons from animal models

Alzabin, S., & Williams, R. O. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.034 · Cited by 96

How to manage patients with corticosteroids in oncology in the era of immunotherapy?

Aldea, M. D., Orillard, É., Mansi, L., Marabelle, A., Scotté, F., Lambotte, O., & Michot, J. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.09.032 · Cited by 96

Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy

Tietze, J. K., Wilkins, D. E. C., Sckisel, G. D., Bouchlaka, M. N., Alderson, K. L., Weiss, J. M., Ames, E., Bruhn, K. W., Craft, N. A., Wiltrout, R. H., et al. (2012) · Blood · doi:10.1182/blood-2011-07-369736 · Cited by 94

Generation and Regulation of CD8+ Regulatory T Cells

Lu, L., & Cantor, H. (2008) · Cellular and Molecular Immunology · doi:10.1038/cmi.2008.50 · Cited by 94

Implications of polygenic risk for personalised colorectal cancer screening

Frampton, M., Law, P., Litchfield, K., Morris, E. J. A., Kerr, D. J., Turnbull, C., Tomlinson, I. P. M., & Houlston, R. S. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv540 · Cited by 94

Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity.

Liu, Y., Shu, Q., Gao, L.-F., Hou, N., Zhao, D., Liu, X., Zhang, X., Xu, L.-Y., Yue, X.-T., Zhu, F., et al. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.07.012 · Cited by 92

A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance

Li, L., Iwamoto, Y., Berezovskaya, A., & Boussiotis, V. A. (2006) · Nature Immunology · doi:10.1038/ni1398 · Cited by 90

Autoimmune T cells retard the loss of function in injured rat optic nerves

Moalem‐Taylor, G., Yoles, E., Leibowitz‐Amit, R., Muller-Gilor, S., Mor, F., Cohen, I. R., & Schwartz, M. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00240-x · Cited by 90

Protective Autoimmunity: A Unifying Model for the Immune Network Involved in CNS Repair

Schwartz, M., & Raposo, C. (2014) · The Neuroscientist · doi:10.1177/1073858413516799 · Cited by 86

Regulatory CD8 + T cells fine-tune the myelin basic protein-reactive T cell receptor Vβ repertoire during experimental autoimmune encephalomyelitis

Jiang, H., Curran, S. A., Ruiz-Vazquez, E. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432871100 · Cited by 82

Pharmacogenomic biomarkers for personalized cancer treatment

Rodríguez‐Antona, C., & Tarón, M. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12321 · Cited by 82

Epidemiologic perspectives on immunosuppressed populations and the immunosurveillance and immunocontainment of cancer

Engels, E. A. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15495 · Cited by 82

Ipilimumab‐induced toxicities and the gastroenterologist

Cheng, R., Cooper, A. J., Kench, J. G., Watson, G., Bye, W. A., McNeil, C. M., & Shackel, N. A. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12888 · Cited by 81

Re-examining the Nature and Function of Self-Reactive T cells

Richards, D. M., Kyewski, B., & Feuerer, M. (2016) · Trends in Immunology · doi:10.1016/j.it.2015.12.005 · Cited by 81

CD4 and CD8 T Cells in Susceptibility/Protection to Collagen-Induced Arthritis in HLA-DQ8-Transgenic Mice: Implications for Rheumatoid Arthritis

Taneja, V., Taneja, N., Paisansinsup, T., Behrens, M. D., Griffiths, M. M., Luthra, H. S., & David, C. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5867 · Cited by 77

Obesity induced T cell dysfunction and implications for cancer immunotherapy

Aguilar, E. G., & Murphy, W. J. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.012 · Cited by 77

Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes

Panoutsakopoulou, V., Huster, K. M., McCarty, N., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20772 · Cited by 73

Obesity and cancer: A mechanistic overview of metabolic changes in obesity that impact genetic instability

Kompella, P., & Vásquez, K. M. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23048 · Cited by 66

Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)—Their Incidence, Management, Multiorgan irAEs, and Rechallenge

Vaddepally, R. K., Doddamani, R., Sodavarapu, S., Madam, N. R., Katkar, R. B., Kutadi, A. P., Mathew, N., Garje, R., & Chandra, A. B. (2022) · Biomedicines · doi:10.3390/biomedicines10040790 · Cited by 64

Steroids use and survival in patients with glioblastoma multiforme: a pooled analysis

Petrelli, F., Stefani, A. D., Ghidini, A., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09731-5 · Cited by 63

Heterologous immunity: Immunopathology, autoimmunity and protection during viral infections

Selin, L. K., Wlodarczyk, M. F., Kraft, A. R. M., Nie, S., Kenney, L. L., Puzone, R., & Celada, F. (2011) · Autoimmunity · doi:10.3109/08916934.2011.523277 · Cited by 62

Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk: A Transcriptome-Wide Association Study in Over 140,000 European Descendants

Wu, L., Wang, J., Cai, Q., Cavazos, T. B., Emami, N. C., Long, J., Shu, X., Lu, Y., Guo, X., Bauer, J. A., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3536 · Cited by 61

CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes

Parodi, A., Battaglia, F., Kalli, F., Ferrera, F., Conteduca, G., Tardito, S., Stringara, S., Ivaldi, F., Negrini, S. M., Borgonovo, G., et al. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1392-z · Cited by 59

Tim-3 adapter protein Bat3 acts as an endogenous regulator of tolerogenic dendritic cell function

Tang, R., Acharya, N., Subramanian, A., Purohit, V., Tabaka, M., Hou, Y., He, D., Dixon, K. O., Lambden, C., Xia, J., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abm0631 · Cited by 59

Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects

Xiao, W. L., Chen, F., Xin, K., et al. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.02.008 · Cited by 57

Activation pathways that drive CD4 + T cells to break tolerance in autoimmune diseases*

Krovi, S. H., & Kuchroo, V. K. (2022) · Immunological Reviews · doi:10.1111/imr.13071 · Cited by 56

IL-33 increases ST2+Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner

Halvorsen, E. C., Franks, S. E., Wadsworth, B. J., Harbourne, B., Cederberg, R. A., Steer, C. A., Martínez-González, I., Calder, J., Lockwood, W. W., & Bennewith, K. L. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1527497 · Cited by 51

Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility

Sud, A., Thomsen, H., Law, P., Försti, A., Filho, M. I. D. S., Holroyd, A., Broderick, P., Orlando, G., Lenive, O., Wright, L. B., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00320-1 · Cited by 49

Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma

Sawai, H., Nishida, N., Khor, S., Honda, M., Sugiyama, M., Baba, N., Yamada, K., Sawada, N., Tsugane, S., Koike, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26217-7 · Cited by 48

Steroidogenic enzyme Cyp11a1 regulates Type 2 CD8 + T cell skewing in allergic lung disease

Jia, Y., Domenico, J. M., Takeda, K., Han, J., Wang, M., Armstrong, M., Reisdorph, N. A., O’Connor, B. P., Lucas, J. J., & Gelfand, E. W. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216671110 · Cited by 44

Androgen receptor-mediated CD8+ T cell stemness programs drive sex differences in antitumor immunity

Yang, C., Jin, J., Yang, Y., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.07.016 · Cited by 44

NFAT1 Supports Tumor-induced Anergy of CD4+ T Cells

Abe, B. T., Shin, D. S., Mocholí, E., & Macián, F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3775 · Cited by 40

Spatial determinants of CD8+ T cell differentiation in cancer

Tooley, K., Escobar, G., & Anderson, A. C. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.04.003 · Cited by 38

Cutting Edge: Antitumor Immunity by Pathogen-Specific CD8 T Cells in the Absence of Cognate Antigen Recognition

Danahy, D. B., Berton, R. R., & Badovinac, V. P. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901172 · Cited by 31

Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases

Saggau, C., Bacher, P., Esser, D., Rasa, M., Meise, S., Mohr, N., Kohlstedt, N., Hutloff, A., Schacht, S.-S., Dargvainiene, J., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.08.005 · Cited by 79

Methods and Trends for Water-Energy-Carbon Emissions Nexus Assessment

Wang, X., Klemeš, J. J., & Varbanov, P. S. (2021) · Chemical engineering transactions · doi:10.3303/cet2183025 · Cited by 1

Good practices & knowledge repository

(2019) · doi:10.18356/6556a659-en

Review of water-energy-food Nexus tools to improve the Nexus modelling approach for integrated policy making

Kaddoura, S., & Khatib, S. E. (2017) · Environmental Science & Policy · doi:10.1016/j.envsci.2017.07.007 · Cited by 228

Studying international doctoral researchers: nexus analysis as a mode of inquiry

Aarnikoivu, M. (2020) · Journal of Praxis in Higher Education · doi:10.47989/kpdc82 · Cited by 3

Challenges and Opportunities in Responding to Nexus Shocks

Howarth, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-94691-7_3